Stock MGNX MACROGENICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus MacroGenics, Inc.

Equities

MGNX

US5560991094

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
15.7 USD -3.27% Intraday chart for MacroGenics, Inc. -2.48% +63.20%
Apr. 10 North American Morning Briefing : Traders Await -2- DJ
Apr. 09 TD Cowen Upgrades MacroGenics to Buy From Hold MT

Evolution of the average Target Price on MacroGenics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cbeb77782dcf285d115531930b79dbc.nigZjqkAG2s4bnphh0D4LKyWAY7IwD_K5AqcpB68Ls4.y0lU6co5bA1KJ0sw9yONXODmebiipwmGlEmtnFLwXf7sbGvj4G5qCXpXNw~3a70b636b67760d20a63bf07d8ef405b

Analyst Recommendations on MacroGenics, Inc.

TD Cowen Upgrades MacroGenics to Buy From Hold MT
JMP Securities Adjusts Price Target on MacroGenics to $22 From $16, Maintains Market Outperform Rating MT
HC Wainwright Adjusts Price Target on MacroGenics to $16 From $14, Maintains Neutral Rating MT
Stifel Adjusts Price Target on MacroGenics to $29 From $17, Keeps Buy Rating MT
BMO Capital Adjusts Price Target on MacroGenics to $24 From $18, Maintains Outperform Rating MT
BTIG Adjusts Price Target on MacroGenics to $24 From $12, Maintains Buy Rating MT
Barclays Raises Price Target on MacroGenics to $23 From $12, Maintains Overweight Rating MT
HC Wainwright Downgrades MacroGenics to Neutral From Buy, Adjusts Price Target to $14 From $12 MT
JMP Securities Adjusts MacroGenics' Price Target to $16 From $10, Maintains Market Outperform Rating MT
Citigroup Upgrades MacroGenics to Buy From Neutral, Raises Price Target to $13 From $7 MT
HC Wainwright Cuts MacroGenics' Price Target to $12 From $14, Keeps Buy Rating MT
Guggenheim Upgrades MacroGenics to Buy From Neutral, Price Target is $12 MT
JMP Securities Adjusts Price Target on MacroGenics to $10 From $8, Maintains Market Outperform Rating MT
BTIG Adjusts Price Target on MacroGenics to $12 From $6, Maintains Buy Rating MT
HC Wainwright Adjusts MacroGenics Price Target to $14 From $12, Maintains Buy Rating MT
Guggenheim Downgrades MacroGenics to Neutral From Buy MT
Citigroup Downgrades MacroGenics to Neutral From Buy, Adjusts Price Target to $7 From $16 MT
Cowen Downgrades MacroGenics to Market Perform From Outperform MT
HC Wainwright Adjusts Price Target on MacroGenics to $12 From $11, Maintains Buy Rating MT
HC Wainwright Adjusts MacroGenics' Price Target to $11 From $10, Maintains Buy Rating MT
HC Wainwright Adjusts MacroGenics' Price Target to $10 from $35, Maintains Buy Rating MT
Citigroup Adjusts MacroGenics' Price Target to $16 From $13, Reiterates Buy Rating MT
SVB Securities Trims MacroGenics' Price Target to $12 From $15, Keeps Outperform Rating MT
Stifel Nicolaus Adjusts MacroGenics Price Target to $14 From $21, Maintains Buy Rating MT
Barclays Adjusts MacroGenics' Price Target to $8 From $18, Reiterates Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
15.7 USD
Average target price
24.78 USD
Spread / Average Target
+57.82%
High Price Target
30 USD
Spread / Highest target
+91.08%
Low Price Target
16 USD
Spread / Lowest Target
+1.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MacroGenics, Inc.

TD Cowen
HC Wainwright
JMP Securities
BMO Capital
Stifel Nicolaus
BTIG
Barclays
Citigroup
Guggenheim
Cowen
SVB Securities LLC
Morgan Stanley
SVB Leerink
SMBC Nikko
Wedbush
Credit Suisse

Ratings for MacroGenics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MGNX Stock
  4. Consensus MacroGenics, Inc.